MINNEAPOLIS, Aug. 15 /PRNewswire-FirstCall/ -- Uroplasty, Inc. announced today that David Kaysen, President and CEO, and Medi Jiwani, Vice President, CFO & Treasurer, will present at the Roth Capital Partners' Investor Conference at the Times Square Westin Hotel in New York, on September 5, 2007 at 3.00 pm central time. Presentation slides will available for viewing on Uroplasty's website (http://www.uroplasty.com) starting at 3.00 pm central time on September 5, 2007.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. Our minimally invasive products treat urinary and fecal incontinence, symptoms of overactive bladder and vesicoureteral reflux. Additionally, some of our soft-tissue bulking agent products are used for the treatment of vocal cord rehabilitation and for augmentation or restoration of soft tissue defects in plastic surgery indications. Some of our products are not approved for use in the U.S.
FOR FURTHER INFORMATION: visit Uroplasty's web page at http://www.uroplasty.com or contact Mr. Kaysen, President & CEO, or Medi Jiwani, Vice President, CFO and Treasurer.
UROPLASTY, INC. 5420 Feltl Road Minnetonka, Minnesota 55343 Tel: 952.426.6140 Fax: 952.426.6199
Uroplasty, Inc.CONTACT: Mr. Kaysen, President & CEO, or Medi Jiwani, Vice President, CFOand Treasurer, +1-952-426-6140, fax, +1-952-426-6199, both of Uroplasty,Inc.
Web site: http://www.uroplasty.com/
